Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.18% | 42.30% | 40.76% | 19.93% | 11.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.18% | 42.30% | 40.76% | 19.93% | 11.68% |
| Cost of Revenue | 19.57% | 24.36% | 12.37% | -1.75% | 3.97% |
| Gross Profit | 37.87% | 46.97% | 48.42% | 26.41% | 13.80% |
| SG&A Expenses | 8.35% | 18.65% | 13.62% | 8.48% | 13.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.50% | 18.99% | 13.89% | 7.74% | 13.86% |
| Operating Income | 44.54% | 27.22% | 69.97% | 18.01% | -18.64% |
| Income Before Tax | 36.58% | 29.80% | 51.76% | 15.03% | -6.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.58% | 29.80% | 51.76% | 15.03% | -6.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.58% | 29.80% | 51.76% | 15.03% | -6.11% |
| EBIT | 44.54% | 27.22% | 69.97% | 18.01% | -18.64% |
| EBITDA | 51.69% | 31.79% | 88.64% | 20.59% | -22.18% |
| EPS Basic | 54.83% | 46.93% | 56.16% | 17.13% | 8.00% |
| Normalized Basic EPS | 54.80% | 43.87% | 55.61% | 17.19% | 5.45% |
| EPS Diluted | 54.83% | 46.93% | 56.16% | 17.13% | 8.00% |
| Normalized Diluted EPS | 54.80% | 43.87% | 55.61% | 17.19% | 5.45% |
| Average Basic Shares Outstanding | 40.41% | 32.27% | 10.02% | 2.53% | 15.33% |
| Average Diluted Shares Outstanding | 40.41% | 32.27% | 10.02% | 2.53% | 15.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |